Wahlstrom Mats Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$69,806.68
Insider Sells Quantity
7
Insider Sells Sum
$17.71M

Insider Activity of Wahlstrom Mats

According to the SEC Form 4 filings, Wahlstrom Mats, being in a position of

  1. director at TriSalus Life Sciences, Inc.,
    оver the last 12 months, has bought 60000 shares for $151,800, and sold 0 shares,
    over all time since 2024-11-20, has bought 75727 shares for $221,607, and sold 0 shares.

Biography of Wahlstrom Mats

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $151,8001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-05-15PurchaseTriSalus Life Sciences, Inc.
TLSI
director
60,000
0.1494%
$2.53$151,800+59.7%
2025-05-23SaleCoherus BioSciences, Inc.
CHRS
director
99,988
0.0843%
$0.74$73,881+99.05%
2024-11-22PurchaseTriSalus Life Sciences, Inc.
TLSI
5,000
0.0164%
$4.55$22,750+10.82%
2024-11-21PurchaseTriSalus Life Sciences, Inc.
TLSI
8,687
0.0277%
$4.44$38,570+13.32%
2024-11-20PurchaseTriSalus Life Sciences, Inc.
TLSI
2,040
0.0061%
$4.16$8,486+23.34%
2020-06-17SaleCoherus BioSciences, Inc.
CHRS
director
200,000
0.2818%
$17.15$3.43M+2.75%
2020-03-03SaleCoherus BioSciences, Inc.
CHRS
director
118,066
0.1718%
$20.12$2.38M-8.89%
2016-12-08SaleCoherus BioSciences, Inc.
CHRS
director
92,380
0.2059%
$27.52$2.54M-42.55%
2016-12-07SaleCoherus BioSciences, Inc.
CHRS
director
14,786
0.0333%
$27.50$406,659-37.55%
2015-08-18SaleCoherus BioSciences, Inc.
CHRS
director
12,744
0.0347%
$33.50$426,949-31.85%
2015-08-17SaleCoherus BioSciences, Inc.
CHRS
director
16,056
0.0427%
$33.91$544,449-34.34%
2015-08-14SaleCoherus BioSciences, Inc.
CHRS
director
233,108
0.6083%
$34.24$7.98M-36.32%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.